Galmed Pharma Shares Drop 30% After Public Offering Prices

By Chris Wack Galmed Pharmaceuticals shares slid 30% to $1.43 after the company said it has entered into securities purchase agreements with two...

Related Keywords

Chris Wack ,Galmed Pharmaceuticals ,Article Normal ,Pharmaceuticals ,Healthcare Life Sciences ,Financial Performance ,Share Price Movement Disruptions ,Corporate Funding ,Ownership Changes ,Acquisitions Mergers Shareholdings ,Corporate Actions ,Corporate Industrial News ,Warrants ,Content Types ,Factiva Filters ,C Amp Ampe Exclusion Filter ,C Amp Ampe Industry News Filter ,Synd ,Glmd ,Il0011313900 ,Share Price Movement ,Disruptions ,Acquisitions ,Mergers ,Shareholdings ,Corporate ,Industrial News ,Healthcare ,Life Sciences ,